These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 817659)

  • 21. Minimum inhibitory concentrations of carbenicillin against Pseudomonas aeruginosa. Investigations on the inoculum effect.
    Rosdahl VT; Rosdahl N
    Chemotherapy; 1971; 16(1):18-28. PubMed ID: 4994994
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-lactamase and the resistance of Pseudomonas aeruginosa to various penicillins and cephalosporins.
    Garber N; Friedman J
    J Gen Microbiol; 1970 Dec; 64(3):343-52. PubMed ID: 4325086
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of carbenicillin in the Gram-negative infections].
    Danieli G; Montroni M
    Clin Ter; 1971 Apr; 57(1):49-62. PubMed ID: 4996911
    [No Abstract]   [Full Text] [Related]  

  • 24. Ticarcillin.
    Med Lett Drugs Ther; 1977 Feb; 19(4):17-8. PubMed ID: 402545
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
    Nicoletti P; Mazzei T; Lamanna S
    G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
    [No Abstract]   [Full Text] [Related]  

  • 29. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
    Segura C; Foz A; Fuster C; Tirado M; Roy C
    Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of Pseudomonas aeruginosa to carbenicillin: an evaluation of susceptibility testing after four years of clinical usage.
    Fiedelman W
    Curr Ther Res Clin Exp; 1974 Dec; 16(12):1287-95. PubMed ID: 4218157
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin.
    Khakoo RA; Kluge RM
    J Antimicrob Chemother; 1979 Jan; 5(1):53-9. PubMed ID: 104952
    [No Abstract]   [Full Text] [Related]  

  • 33. Bacteriological studies with cefsulodin (CGP 7174/E), the first antipseudomonal cephalosporin.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):563-7. PubMed ID: 115832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
    Hernández-Tejedor A; Merino-Vega CD; Martín-Vivas A; Ruiz de Luna-González R; Delgado-Iribarren A; Gabán-Díez Á; Temprano-Gómez I; de la Calle-Pedrosa N; González-Jiménez AI; Algora-Weber A
    Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity of Pseudomonas aeruginosa to ticarcillin and carbenicillin (comparative study)].
    García Rodríguez JA; Gómez García AC; García Sánchez JE; Saenz González M
    Rev Clin Esp; 1977 Aug 15-31; 146(3-4):157-9. PubMed ID: 411159
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
    Parry MF; Neu HC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies on bacterial colonization. The effects of beta-lactam antibiotics on the growth of Escherichia coli and Pseudomonas aeruginosa in mixed culture.
    Tsuji A
    Microbiol Immunol; 1979; 23(8):693-704. PubMed ID: 120484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy.
    Davis SD; Iannetta A; Wedgwood RJ
    J Infect Dis; 1971 Jul; 124(1):104-6. PubMed ID: 4335448
    [No Abstract]   [Full Text] [Related]  

  • 39. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.
    Adler JL; Finland M
    Appl Microbiol; 1971 Nov; 22(5):870-5. PubMed ID: 4332044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.